Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer.
about
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesAssociation Between ABCB1 (MDR1) Gene Polymorphism and Unresponsiveness Combined Therapy in Chronic Hepatitis C virusTat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy.Increased adenovirus Type 5 mediated transgene expression due to RhoB down-regulationChemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab-Paclitaxel Plus Gemcitabine.
P2860
Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@ast
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@en
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@nl
type
label
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@ast
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@en
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@nl
prefLabel
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@ast
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@en
Combination of a MDR1-targeted ...... of pretreated ovarian cancer.
@nl
P2093
P2860
P921
P1476
Combination of a MDR1-targeted ...... y of pretreated ovarian cancer
@en
P2093
Anne Kathrin Welter
Anne Volkmer
Daniel T Rein
Dirk Bauerschlag
Gerd Bauerschmitz
Markus C Fleisch
Martina Breidenbach
Thomas Schöndorf
Wolfgang Janni
P2860
P2888
P304
P356
10.1007/S00432-011-1135-5
P50
P577
2012-01-01T00:00:00Z